Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 71.69% | -142.56% | -639.14% | -801.07% | -757.01% |
| Total Depreciation and Amortization | 5.37% | 9.17% | 7.03% | 6.03% | 3.20% |
| Total Amortization of Deferred Charges | 642.44% | 1,969.37% | 1,871.98% | 1,810.64% | 1,332.61% |
| Total Other Non-Cash Items | -131.17% | 7.78% | 393,197.37% | 5,829,285.71% | 200,830.57% |
| Change in Net Operating Assets | 346.25% | 806.32% | 776.27% | 36.39% | 656.05% |
| Cash from Operations | 12.52% | -7.14% | 6.16% | -23.75% | -10.58% |
| Capital Expenditure | -11.32% | -24.16% | 52.36% | -226.63% | -197.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.32% | -24.16% | 51.92% | -234.74% | -203.48% |
| Total Debt Issued | -37.19% | 15.61% | 6.17% | 43.94% | 135.27% |
| Total Debt Repaid | -77.90% | -113.96% | 6.91% | 1.33% | -4.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 89.04% | 32.72% | -132.33% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -38.57% | 16.81% | -9.53% | 16.01% | 29.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -254.67% | 662.63% | -319.69% | -221.18% | 654.45% |